X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (62) 62
humans (54) 54
male (41) 41
female (40) 40
middle aged (38) 38
hematology (36) 36
oncology (35) 35
aged (31) 31
adult (27) 27
rituximab (24) 24
treatment outcome (21) 21
abridged index medicus (17) 17
lymphoma (17) 17
article (16) 16
aged, 80 and over (14) 14
cancer (13) 13
lymphomas (13) 13
antineoplastic agents - therapeutic use (12) 12
antineoplastic combined chemotherapy protocols - therapeutic use (12) 12
chemotherapy (11) 11
antineoplastic combined chemotherapy protocols - adverse effects (10) 10
clinical trials and observations (10) 10
survival (10) 10
therapy (10) 10
transplantation (10) 10
cyclophosphamide (9) 9
disease-free survival (9) 9
research (9) 9
antineoplastic agents - adverse effects (8) 8
medicine & public health (8) 8
pi3k (8) 8
prognosis (8) 8
recurrence (8) 8
stem-cell transplantation (8) 8
analysis (7) 7
care and treatment (7) 7
hematology, oncology and palliative medicine (7) 7
purines - therapeutic use (7) 7
risk factors (7) 7
antineoplastic combined chemotherapy protocols - administration & dosage (6) 6
disease (6) 6
drug therapy (6) 6
hemic and lymphatic diseases (6) 6
hodgkin's disease (6) 6
kaplan-meier estimate (6) 6
lymphoma, large b-cell, diffuse - pathology (6) 6
non-hodgkins-lymphoma (6) 6
purines - adverse effects (6) 6
quinazolinones - therapeutic use (6) 6
usage (6) 6
young adult (6) 6
antineoplastic agents - administration & dosage (5) 5
b-cell lymphoma (5) 5
doxorubicin (5) 5
drug administration schedule (5) 5
follicular lymphoma (5) 5
health care sciences & services (5) 5
hodgkin disease - drug therapy (5) 5
hodgkin lymphoma (5) 5
immune system diseases (5) 5
lymphoma, large b-cell, diffuse - drug therapy (5) 5
medical colleges (5) 5
multicenter (5) 5
neoplasm staging (5) 5
non-hodgkin-lymphoma (5) 5
nursing (5) 5
pain medicine (5) 5
peripheral nervous system diseases - chemically induced (5) 5
quinazolinones - adverse effects (5) 5
rituximab - administration & dosage (5) 5
thalidomide - analogs & derivatives (5) 5
trial (5) 5
bendamustine (4) 4
biomarkers (4) 4
blood (4) 4
breast cancer (4) 4
brentuximab vedotin (4) 4
cal-101 (4) 4
chemotherapy-induced peripheral neuropathy (4) 4
class ia phosphatidylinositol 3-kinase - antagonists & inhibitors (4) 4
combination (4) 4
diagnosis (4) 4
diffuse large b-cell lymphoma (4) 4
follow-up (4) 4
hiv (4) 4
inhibitor (4) 4
leukemia (4) 4
leukemia, lymphocytic, chronic, b-cell - drug therapy (4) 4
lymphocytes b (4) 4
lymphoma - mortality (4) 4
lymphoma, non-hodgkin - drug therapy (4) 4
management (4) 4
neoplasm grading (4) 4
neoplasms - complications (4) 4
neutropenia (4) 4
non-hodgkin's lymphoma (4) 4
non-hodgkin's lymphomas (4) 4
organoplatinum compounds - administration & dosage (4) 4
patients (4) 4
proportional hazards models (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 03/2014, Volume 370, Issue 11, pp. 1008 - 1018
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 01/2020, Volume 126, Issue 2, pp. 293 - 303
Background Salvage immunochemotherapy followed by high‐dose chemotherapy and autologous stem cell transplantation is the standard‐of‐care second‐line treatment... 
high‐grade B‐cell lymphoma | relapsed/refractory | diffuse large B‐cell lymphoma | salvage therapy | chemotherapy | Autografts | Dexamethasone | Ifosfamide | Medical treatment | Etoposide | Stem cell transplantation | Rituximab | Transplantation | Prednisone | Survival | Doxorubicin | Vincristine | Lymphoma | Cyclophosphamide | Chemotherapy | Cytarabine | Platinum | Stem cells | Lymphomas | Methotrexate | Hodgkin's disease
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2019, Volume 37, Issue 11, pp. 912 - 922
Journal Article
British Journal of Haematology, ISSN 0007-1048, 08/2016, Volume 174, Issue 4, pp. 571 - 581
Journal Article
Journal Article
Journal Article
British journal of haematology, ISSN 0007-1048, 12/2019
While patients with double-hit lymphoma (DHL) are now frequently treated with intensive front-line immunochemotherapy, outcomes for those who fail these... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2014, Volume 32, Issue 18, pp. 1941 - 1967
Purpose To provide evidence-based guidance on the optimum prevention and treatment approaches in the management of chemotherapy-induced peripheral neuropathies... 
ACUTE PAIN SYNDROME | PROSPECTIVE SURVEILLANCE MODEL | ONCOLOGY | DOUBLE-BLIND | REDUCED GLUTATHIONE | QUALITY-OF-LIFE | CISPLATIN-INDUCED TOXICITIES | VITAMIN-E SUPPLEMENTATION | PLACEBO-CONTROLLED TRIAL | OXALIPLATIN-RELATED NEUROTOXICITY | ADVANCED COLORECTAL-CANCER | Thiophenes - therapeutic use | Peripheral Nervous System Diseases - chemically induced | United States | Humans | Peripheral Nervous System Diseases - physiopathology | Antineoplastic Agents - administration & dosage | Ketamine - administration & dosage | Incidence | Neuralgia - prevention & control | Peripheral Nervous System Diseases - prevention & control | Antineoplastic Agents - adverse effects | Amines - therapeutic use | Neuralgia - etiology | Adult | gamma-Aminobutyric Acid - therapeutic use | Drug Therapy, Combination | Peripheral Nervous System Diseases - complications | Severity of Illness Index | Analgesics - therapeutic use | Cyclohexanecarboxylic Acids - therapeutic use | Gels | Baclofen - administration & dosage | Comorbidity | Survivors | Anticonvulsants - therapeutic use | Treatment Outcome | Evidence-Based Medicine | Neuralgia - drug therapy | Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Antidepressive Agents, Tricyclic - therapeutic use | Duloxetine Hydrochloride | Quality of Life | Peripheral Nervous System Diseases - drug therapy | Amitriptyline - administration & dosage
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 12/2019, Volume 145, Issue 3, pp. 467 - 467
The following discrepancies and errors were found in the original publication: 
Medicine & Public Health | Neurology | Oncology | Rituximab | Methotrexate | Substantia alba | Lymphoma | Central nervous system
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 12/2019, Volume 145, Issue 3, pp. 461 - 466
White matter changes (WMCs) can develop following systemic chemotherapy in patients with primary central nervous system lymphomas (PCNSLs), but the frequency... 
High-dose methotrexate | Neurology | White matter changes | Medicine & Public Health | Rituximab | Oncology | Primary central nervous system lymphoma | Leukoencephalopathy | Chemotherapy | Magnetic resonance imaging | Central nervous system | Nervous system | Cognition | Radiation therapy | Methotrexate | Substantia alba | Lymphoma
Journal Article
Blood, ISSN 0006-4971, 05/2014, Volume 123, Issue 22, pp. 3390 - 3397
Journal Article
Cancer, ISSN 0008-543X, 07/2014, Volume 120, Issue 14, pp. 2122 - 2129
Journal Article